Is Neuronal Histamine Signaling Involved in Cancer Cachexia? Implications and Perspectives

by Hannes Zwickl, Elisabeth Zwickl-Traxler, Martin Pecherstorfer
Published 2019-12-01

Myeloma Bone Disease: Update on Pathogenesis and Novel Treatment Strategies

by Sonia Vallet, Julia-Marie Filzmoser, Martin Pecherstorfer, Klaus Podar
Published 2018-10-01

Evaluation of personalized cancer therapies based on comprehensive genomic profiling in a middle-sized oncologic center in Austria, the University Clinic Krems

by Josef Singer, Elias Brauneck, Elisabeth Zwickl-Traxler, Martin Pecherstorfer
Published 2021-05-01

Efficacy and safety of immune checkpoint inhibitors in patients with advanced non–small cell lung cancer (NSCLC): a systematic literature review

by Gernot Wagner, Hannah Karolina Stollenwerk, Irma Klerings, Martin Pecherstorfer, Gerald Gartlehner, Josef Singer
Published 2020-01-01

Retrospective analysis of the prevalence of specialised palliative care services for patients with metastatic breast cancer

by Martin Filipits, Eva Maria Jäger, Anna Glechner, Elisabeth Zwickl-Traxler, Gabriele Schmoranzer, Martin Pecherstorfer, Gudrun Kreye
Published 2020-10-01

Effect of cachexia on bone turnover in cancer patients: a case-control study

by Hannes Zwickl, Elisabeth Zwickl-Traxler, Alexander Haushofer, Josef Seier, Klaus Podar, Michael Weber, Klaus Hackner, Nico Jacobi, Martin Pecherstorfer, Sonia Vallet
Published 2021-06-01

Evaluation of Antibody Responses to COVID-19 Vaccines among Solid Tumor and Hematologic Patients

by Josef Singer, Nguyen-Son Le, Daniel Mattes, Valerie Klamminger, Klaus Hackner, Nicole Kolinsky, Michaela Scherb, Peter Errhalt, Gudrun Kreye, Martin Pecherstorfer, Sonia Vallet, Klaus Podar
Published 2021-08-01

Reduced LDL-Cholesterol and Reduced Total Cholesterol as Potential Indicators of Early Cancer in Male Treatment-Naïve Cancer Patients With Pre-cachexia and Cachexia

by Hannes Zwickl, Klaus Hackner, Harald Köfeler, Eva-Christina Krzizek, Besnik Muqaku, Dietmar Pils, Dietmar Pils, Hubert Scharnagl, Tora S. Solheim, Tora S. Solheim, Elisabeth Zwickl-Traxler, Martin Pecherstorfer
Published 2020-08-01

The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: analysis of an Austrian multicent...

by Jakob Michael Riedl, Florian Posch, Gerald Prager, Wolfgang Eisterer, Leopold Oehler, Thamer Sliwa, Klaus Wilthoner, Andreas Petzer, Petra Pichler, Eva Hubmann, Thomas Winder, Sonja Burgstaller, Markus Korger, Johannes Andel, Richard Greil, Hans-Joerg Neumann, Martin Pecherstorfer, Kathrin Philipp-Abbrederis, Angela Djanani, Birgit Gruenberger, Friedrich Laengle, Ewald Wöll, Armin Gerger
Published 2020-04-01

Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL‐8a mabtenance trial

by Alexander Egle, Thomas Melchardt, Petra Obrtlíková, Lukáš Smolej, Tomáš Kozák, Michael Steurer, Johannes Andel, Sonja Burgstaller, Eva Mikušková, Liana Gercheva, Thomas Nösslinger, Tomáš Papajík, Miriam Ladická, Michael Girschikofsky, Mikuláš Hrubiško, Ulrich Jäger, Daniela Voskova, Martin Pecherstorfer, Eva Králiková, Christina Burcoveanu, Emil Spasov, Andreas Petzer, Georgi Mihaylov, Julian Raynov, Horst Oexle, August Zabernigg, Emília Flochová, Stanislav Palášthy, Olga Stehlíková, Michael Doubek, Petra Altenhofer, Lukas Weiss, Teresa Magnes, Lisa Pleyer, Anton Klingler, Jiří Mayer, Richard Greil
Published 2019-04-01